Comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD

被引：1
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med Cluj Napoca, Dept Ophthalmol, Cluj Napoca, Romania
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2016年 / 26卷 / 05期
关键词：
D O I：
10.5301/ejo.5000845
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E138 / E138
页数：1
相关论文
共 50 条
  • [1] Author's reply to comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD
    Waizel, Maria
    Kazerounian, Sara
    Rickmann, Annekatrin
    Wolf, Katharina
    Blanke, Bjoern R.
    Todorova, Margarita G.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (05) : E139 - E140
  • [2] Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD
    Thorell, Mariana R.
    Nunes, Renata Portella
    Chen, Gene W.
    Doshi, Rishi R.
    Dugar, Jyoti
    George, Mathew K.
    Kim, Brian T.
    Lowrance, Matthew D.
    Modi, Dimple
    Nahas, Zayna
    Gregori, Giovanni
    Yehoshua, Zohar
    Feuer, William
    Rosenfeld, Philip J.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (06): : 526 - 533
  • [3] Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
    Maria Waizel
    Margarita G. Todorova
    Michael Masyk
    Katharina Wolf
    Annekatrin Rickmann
    Khaled Helaiwa
    Björn R. Blanke
    Peter Szurman
    [J]. BMC Ophthalmology, 17
  • [4] Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
    Waizel, Maria
    Todorova, Margarita G.
    Masyk, Michael
    Wolf, Katharina
    Rickmann, Annekatrin
    Helaiwa, Khaled
    Blanke, Bjoern R.
    Szurman, Peter
    [J]. BMC OPHTHALMOLOGY, 2017, 17
  • [5] Intravitreal Aflibercept in Eyes with Neovascular AMD Requiring Frequent Retreatment with Intravitreal Bevacizumab or Ranibizumab
    Thorell, Mariana Rossi
    Nunes, Renata Portella
    Gregori, Giovanni
    Feuer, William J.
    Rosenfeld, Philip J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] Treatment of Neovascular AMD by Aflibercept (Eylea) with Proreactive protocol
    Gonzalez, Corinne
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [7] Treatment of neovascular AMD by Aflibercept (Eylea) with proreactive protocol
    Gonzalez, C.
    [J]. ACTA OPHTHALMOLOGICA, 2014, 92
  • [8] Factors associated with poor response to aflibercept after switching from ranibizumab or bevacizumab in neovascular age-related macular degeneration (AMD)
    Cheng, Sarah
    Leng, Theodore
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [9] Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
    Avery, Robert L.
    Castellarin, Alessandro A.
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Pieramici, Dante Joseph
    See, Robert
    Couvillion, Stephen
    Nasir, Ma'an A.
    Rabena, Melvin D.
    Le, Kha
    Maia, Mauricio
    Visich, Jennifer E.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (12) : 1636 - 1641
  • [10] Intravitreal Aflibercept for Recalcitrant Neovascular AMD
    Maldonado, Maria
    Brown, David
    Wyko, Charles
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345